RISE-Vac Reaching the hard-to-reach: Increasing access and vaccine uptake among the prison population in Europe
Project summary
Please click here to download the Rise-Vac information leaflet.
RISE-Vac aims to improve the health of prison population in Europe by promoting vaccine literacy, enhancing vaccine offer and increasing vaccine uptake.
Tackling low vaccine coverage is a public health priority. Despite efforts, pockets of unvaccinated individuals persist in Europe. People in prison constitute a sizeable fraction of the population, in absolute number and for its rapid turnover. Incarcerated individuals largely belong to socially deprived communities with low socio-economic status and education level, high disease burden and prevalence of risk behaviours; and often, sub-optimal access to care. Prisons may be a gateway to offer appropriate and high-quality healthcare and vaccination services to individuals while in detention.
To respond to this public health priority, the RISE-Vac consortium brings together multisectoral skills, solid experience and well-established networks in the prison health field, reflecting epidemiological and structural diversities of European context.
Using state-of-the-art methodologies, RISE-Vac will
- gather existing evidence on vaccination strategies and services targeting people in prison and combine it with prospectively collected data on (i) attitudes and vaccine learning among prison population and staff; (ii) vaccination status and vaccine uptake during incarceration
- use a co-creation approach to develop information and training materials tailored to people in prison and staff to increase their vaccine learning
- develop and pilot models of vaccination delivery to respond to the needs of prison population, prison settings characteristics and national priorities.
The benefits resulting from RISE-Vac activities will also accrue in the general population, increasing overall vaccine coverage. By upholding the principle that prison health is public health, the RISE-Vac project will provide tools and data-driven, evidence-based options to guide European countries in improving health status of people in prison and European population at large.
RISE-Vac stakeholders and expected impact
Advisory Board Members
Institution |
City, Country |
Contract Person |
European Centre for Disease Prevention and Control (ECDC) |
Stockholm, Sweden |
Dr Erika Duffell |
European Monitoring Office for Drugs and Drug Addiction (EMCDDA) |
Lisbon, Portugal |
Ms Maria Linda Montanari |
World Health Organisation Health in Prison Programme (WHO HIPP) |
Moscow, Russia |
Prof Filipa Alves da Costa |
United Nations Office on Drugs and Crime (UNODC) |
Wien, Austria |
Dr Ehab Salah |
University of Wien |
Wien, Austria |
Prof Joerg Pont |
Romanian Angel Appeal Foundation |
Bucarest, Romania |
Dr Lucia Mihailescu |
Italian National Institute of Health |
Rome, Italy |
Dr Silvia Declich |
Irish Penal Reform Trust |
Dublin, Ireland |
Niall Walsh |
The University of Southampton |
London, United Kingdom |
Dr Emma Plugge |
If you have any further questions on RISE-Vac, please contact: lara.tavoschi@unipi.it
Follow us on Twitter and Facebook
This project was funded by the European Union’s Health Programme (2014-2020).
The content of this website represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the European Health and Digital Executive Agency (HaDEA) or any other body of the European Union. The European Commission and the Agency do not accept any responsibility for use that may be made of the information it contains.